Martin Tami Tillotson 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Award
Common Stock
2023-02-22+750→ 90,323 total - Disposition to Issuer
Restricted Stock Units
2023-02-22−750→ 2,250 total→ Common Stock (750 underlying)
Footnotes (3)
- [F1]Includes an aggregate of 853 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023.